• Home
  • Search Results
  • Early-onset foveal involvement in retinitis punctata albescens with mutations in RLBP1.

Early-onset foveal involvement in retinitis punctata albescens with mutations in RLBP1.

JAMA ophthalmology (2013-08-10)
Elodie Dessalces, Béatrice Bocquet, Jérôme Bourien, Xavier Zanlonghi, Robert Verdet, Isabelle Meunier, Christian P Hamel

Retinitis punctata albescens (RPA) is an autosomal recessive form of retinitis pigmentosa characterized by white dotlike deposits in the fundus, in most cases caused by mutations in RLBP1. To study disease progression and visual function in RPA. We performed clinical and molecular investigations in patients with RPA at various ages, from November 5, 2003, through June 20, 2012, with no planned patient follow-up. The National Reference Center for Genetic Sensory Diseases (Montpellier). Eleven patients with RPA (mean age, 24 [range, 3-39] years) from 7 families and 11 control subjects undergoing evaluation. Optical coherence tomography measurements. Screening for mutations by polymerase chain reaction sequencing of the 9 RLBP1 exons. Patients underwent standard ophthalmic examination, fundus imaging, autofluorescence testing, Goldmann visual field measurement, optical coherence tomography, adaptive optics-based infrared fundus ophthalmoscopy, dark adaptometry, and electroretinography. We found 2 novel RLBP1 mutations (p.Tyr111X and p.Arg9Cys), and 8 patients from Morocco were homozygous for the recurrent 7.36-kilobase RLBP1 deletion of exons 7 through 9. All patients had night blindness (before age 6 years in 10). The dotlike deposits were generally dense but could be rare, appearing in adaptive optics as elongated structures with variable orientation and no foveal involvement. We found no specific refractive error, and visual acuity varied widely from normal (1.2) to counting fingers. Variable degrees of visual field impairment were present, and all patients had severely decreased electroretinographic responses with predominant rod impairment. No correlation between visual acuity (P = .27) or visual field and age (P = .08) was present. On optical coherence tomography, the mean (SD) central foveal (122 [23] vs 187 [30] µm in controls) and foveal (147 [19] vs 217 [17] µm) thicknesses were significantly (P < .01) decreased, independently of age, whereas the retinal thickness at the 3- and 6-mm rings around the fovea progressively decreased with age. Mean (SD) cone number was normal in 1 patient aged 13 years (21,000/mm² [2000/mm²]) but dropped to 10,500/mm² (5244/mm²), 8667/mm² (2944/mm²), and 5833/mm² (983/mm²) in 3 other patients aged 39, 32, and 29 years, respectively. Patients with RPA show variable degrees of foveal cone death, even at an early stage. This finding has implications for future treatment.

Product Number
Product Description

Anti-RLBP1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.